Frazier Life Sciences Management, L.P. Portfolio Holdings

Frazier Life Sciences Management, L.P.

  • $2.36 Billion
  • Q3 2025

Frazier Life Sciences Management, L.P. has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $2.36 Billion distributed in 47 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Mirum Pharmaceuticals, Inc. with a value of $498M, Verona Pharma PLC with a value of $361M, Bridge Bio Pharma, Inc. with a value of $200M, Arcutis Biotherapeutics, Inc. with a value of $186M, and Phathom Pharmaceuticals, Inc. with a value of $143M.

Examining the 13F form we can see an increase of $469M in the current position value, from $1.9B to 2.36B.

Frazier Life Sciences Management, L.P. is based out at Menlo Park, CA

Below you can find more details about Frazier Life Sciences Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $2.36 Billion
Healthcare: $2.36 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 47
  • Current Value $2.36 Billion
  • Prior Value $1.9 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 4 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email